EYPT News and Press, EyePoint Pharmaceuticals Inc. From 04/26/23

WATERTOWN, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced it will host a conference call and live webcast at 8:...

2023-04-24 10:08:54 ET Gainers: IN8bio ( INAB ) +121% . IDEAYA Biosciences ( IDYA ) +27% . ZyVersa Therapeutics ( ZVSA ) +26% .  Koninklijke Philips ( PHG ) +15% . Kiora Pharmaceuticals ( KPRX ) +9% . Losers: Scilex H...

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is one of today's top gainers. The company's shares are currently up 32.75% on the day to $7.54. EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the Unit...

2023-04-21 10:03:36 ET Gainers: EyePoint Pharmaceuticals ( EYPT ) +19% . Tenaya Therapeutics ( TNYA ) +21% . Community Health Systems ( CYH ) +11% . NovaBay Pharmaceuticals ( NBY ) +11% . Aziyo Biologics ( AZYO ) +8% . Loser...

2023-04-20 17:51:34 ET Gainers: ContextLogic ( WISH ) +28% . EyePoint Pharmaceuticals ( EYPT ) +7% . Caribou Biosciences ( CRBU ) +5% . Ocular Therapeutix ( OCUL ) +3% . Coherus BioSciences ( CHRS ) +3% . Losers: CRISPR T...

- Significant investigator and patient interest drove strong recruitment, exceeding enrollment goals - Topline DAVIO 2 data anticipated in Q4 2023 WATERTOWN, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing ...

- Positive neuroprotective effect of vorolanib, the active drug in EYP-1901, in a widely validated retinal detachment model demonstrates a potential new mechanism of action for the treatment of retinal disease - - Clinical outcomes from real-world CALM registry study of YUTIQ ® ...

Gainers: A-Mark Precious Metals ( AMRK ) +6% . Absci  ( ABSI ) +5% . Verve Therapeutics ( VERV ) +5% . Coherus BioSciences ( CHRS ) +5% . SouthState  ( SSB ) +4% . Losers: Cytek Biosciences ( CTKB ) -12% . 2U ...

EyePoint Pharmaceuticals, Inc. (EYPT) Q4 2022 Earnings Conference Call March 02, 2023 08:30 A.M. ET Company Participants Nancy Lurker - CEO George O. Elston - CFO Jay Duker - President and COO Scott Jones - Chief Commercial Officer Conference Call Participant...

EyePoint Pharmaceuticals ( NASDAQ: EYPT ) stock fell ~8% on Thursday after the company reported its Q4 results. Net loss widened to -$43.45M, compared to -$19.43M in Q4 2021. Meanwhile, total revenue in Q4 declined -8.7% Y/Y to $10.53M, but did manage to beat analysts expectat...